Adapalene

What is Adapalene?

What adapalene is

Adapalene is a third-generation topical retinoid sold as Differin (now available over-the-counter at 0.1% strength as of 2016) for treating acne. It binds to nuclear retinoic-acid receptors in the skin, promoting cell turnover and reducing inflammation in acne lesions1.

Adapalene is generally better tolerated than tretinoin, with less skin irritation and similar efficacy for mild-to-moderate acne2. Its OTC availability has made it the most accessible prescription-strength retinoid.

Why adapalene is still flagged in pregnancy

Despite being a newer molecule, adapalene shares the same retinoid receptor mechanism that drives teratogenicity in other vitamin A derivatives. Animal studies have shown developmental effects at high doses, although no human cases of adapalene-related birth defects have been documented3.

Two factors drive the precautionary “avoid” recommendation:

• Class effect. All retinoids (oral and topical, prescription and OTC) are grouped together in pregnancy guidance because the underlying mechanism is shared.
• Limited human data. Because pregnancy-specific trials of adapalene have not been ethically possible, the safety margin is unknown.

The Australian Therapeutic Goods Administration classifies adapalene as Pregnancy Category D (positive evidence of human fetal risk based on adverse reaction data); the FDA classifies it as Category C4. ACOG and AAD both recommend avoiding all topical retinoids in pregnancy.

If you’ve been using adapalene

Discontinue use upon learning of pregnancy and inform your provider. As with all topical retinoids, the literature does not show a clear association with birth defects from typical OTC use — the avoidance is precautionary, not based on documented harm.